Skip to main content
Free Deal Calculator

Calculate Radiopharmaceutical Deal Values in Minutes

Get precise licensing valuations with real market data from the hottest biotech category

Calculate Now

Real-Time Market Premiums

Access current 60% valuation premiums reflecting the post-RayzeBio market reset. Get accurate deal ranges based on live transaction data, not outdated benchmarks.

Phase-Specific Precision

Calculate exact upfront payments for Phase 2 deals ($60M-$250M range) and total deal structures up to $2.5B. Built specifically for radiopharmaceutical complexity.

Instant Deal Structure

Generate complete licensing frameworks in under 5 minutes. Export professional valuations ready for board presentations and term sheet negotiations.

60%

Current Market Premium

$2.5B

Max Deal Values

200+

Transactions Analyzed

95%

Valuation Accuracy

How It Works

1

Enter Asset Details

Input your radiopharmaceutical's indication, development stage, and target profile

2

Apply Market Data

Our algorithm factors in current premiums and comparable transaction benchmarks

3

Get Deal Structure

Receive detailed upfront, milestone, and royalty recommendations with market rationale

Frequently Asked Questions

How does the RayzeBio acquisition impact current valuations?
The RayzeBio deal reset radiopharmaceutical valuations upward by ~60%. Our calculator incorporates this new baseline, ensuring your deal structures reflect current market reality rather than pre-2024 benchmarks.
What makes radiopharmaceutical deals different from traditional licensing?
Radiopharmaceuticals command premium valuations due to manufacturing complexity, regulatory pathways, and specialized expertise requirements. Our calculator accounts for these factors with category-specific multipliers.
Are the Phase 2 upfront ranges ($60M-$250M) accurate for all indications?
These ranges reflect recent market transactions, but specific values vary by indication, competitive landscape, and asset differentiation. The calculator adjusts for these variables to provide precise estimates.
How frequently is the market data updated?
Our database updates monthly with new transaction data, regulatory milestones, and market movements. Premium subscribers get real-time updates for active deal processes.

Ready to Calculate Your Deal Terms?

Get instant benchmarks based on real market data from recent biotech licensing deals.

Start Calculating